Glen Eagle Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-300
| Closed | -$10.3K | – | 1016 |
|
|
2022
Q1 | $10.3K | Hold |
300
| – | – | ﹤0.01% | 616 |
|
|
2021
Q4 | $13.1K | Hold |
300
| – | – | ﹤0.01% | 574 |
|
|
2021
Q3 | $15.2K | Hold |
300
| – | – | ﹤0.01% | 608 |
|
|
2021
Q2 | $15.6K | Hold |
300
| – | – | ﹤0.01% | 602 |
|
|
2021
Q1 | $13.7K | Hold |
300
| – | – | ﹤0.01% | 602 |
|
|
2020
Q4 | $13.8K | Buy |
300
+100
| +50% | +$4.59K | 0.01% | 571 |
|
|
2020
Q3 | $7.79K | Hold |
200
| – | – | ﹤0.01% | 637 |
|
|
2020
Q2 | $7.59K | Hold |
200
| – | – | ﹤0.01% | 607 |
|
|
2020
Q1 | $5.37K | Buy |
+200
| New | +$5.37K | ﹤0.01% | 608 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 915 |
|